Real Opportunities.

Businesses

Systems built through execution. Scaled through discipline.

No venture dependence. No abstraction layer.Each system was built to remove friction inside real-world constraints—care delivery, supply chains, distribution. Execution was the constant. The outcome wasn't a portfolio. It was infrastructure.

01

MEDLAB INTERNATIONAL

CEO / Founder

2015–Present

Ohio

Built from a single $8,000 credit line with no external capital.MedLab established a direct supply chain for medical, surgical, and research products—removing dependency on fragmented vendors and inflated procurement channels.The early years were operational. Packing, fulfillment, vendor negotiation. Every layer built manually.That system scaled into a core distribution engine within a multi-nine-figure healthcare portfolio.

BOOTSTRAPPED FROM $8,000

INC. 5000 (#25, #3456)

INC. BEST WORKPLACE

02

VAXXEN LABS

Founder

2016–Present

Marketplace Infrastructure

Global

Built to control distribution at the marketplace level. The Amazon layer extends supply chain control into consumer channels—owning visibility, pricing, fulfillment, and velocity without reliance on third-party retail.The system is operational, not brand-driven. Ranking, logistics, and conversion as levers.It converts inventory into reach at scale.

GLOBAL MARKETPLACE DISTRIBUTION

HIGH-VOLUME SKU VELOCITY

DIRECT-TO-CONSUMER CONTROL LAYER

03

MINUTEMD

Founder / CEO

2016–Present

Cortland, Ohio

Built to remove time as a barrier to care.MinuteMD delivers immediate access to providers, prescriptions, and clinical support—without scheduling friction or geographic constraint.The system prioritizes response speed and continuity.Care becomes on-demand, not delayed.

24 / 7 TELEHEALTH ACCES

NATIONWIDE PATIENT REACH

HIGH-FREQUENCY UTILIZATION

04

AMBLE

Founder

2023–Present

U.S.

Built to simplify access to metabolic treatment.Amble removes friction across pricing, eligibility, and fulfillment—compressing the GLP-1 pathway into a single system.The model is not clinical innovation. It is access optimization.Lower complexity expands reach.

GLP-1 ACCESS PLATFORM

COST COMPRESSION MODEL

RAPID ADOPTION CURVE